- Approval Id
- fbf17648ec239f39
- Drug Name
- CLARICLEAR NASAL SPRAY 0.05%
- Product Name
- CLARICLEAR NASAL SPRAY 0.05%
- Approval Number
- SIN02656P
- Approval Date
- 1989-04-27
- Registrant
- BAYER (SOUTH EAST ASIA) PTE LTD
- Licence Holder
- BAYER (SOUTH EAST ASIA) PTE LTD
- Drug Type
- Therapeutic
- Forensic Classification
- General Sale List
- Dosage Form
- SPRAY
- Dosage
- <p><strong>DOSAGE AND ADMINISTRATION: For adults and children six years of age and older:</strong> Two or three sprays into each nostril twice daily, morning and evening. With the head upright, place the sprays nozzle into the nostril without completely occluding the nostril. During each administration, the patient should bend his head slightly forward and spray the dose into each nostril by squeezing the bottle rapidly and strongly.</p>
- Route Of Administration
- NASAL
- Indication Info
- <p><strong>INDICATIONS:</strong> Clariclear® Nasal Spray is indicated for symptomatic relief of nasal and nasal pharyngeal congestion due to the common cold, sinusitis, hay fever or other upper respiratory allergies.</p>
- Contraindications
- <p><strong>CONTRAINDICATIONS:</strong> Oxymetazoline-containing nasal sprays should not be used:</p>
<ul>
<li>in patients with known hypersensitivity to oxymetazoline or other adrenergic agents, or to any component of the medicinal product;</li>
<li>in patients taking monoamine oxidase inhibitors (MAOIs) or in patients who have taken MAOIs in the previous two weeks;</li>
<li>in patients with narrow-angle glaucoma;</li>
<li>in patients after trans-sphenoidal hypophysectomy;</li>
<li>where there is inflammation of the skin and mucosa of the nasal vestibule and encrustation (rhinitis sicca);</li>
<li>in patients with acute cardiovascular disease or cardiac asthma;</li>
<li>in patients with severe high blood pressure.</li>
</ul>
- Atc Code
- R01AA05
- Atc Item Name
- oxymetazoline
- Pharma Manufacturer Name
- BAYER (SOUTH EAST ASIA) PTE LTD
